B-cell Acute Lymphoblastic Leukaemia Archives

New standard-of-care for paediatric B-cell ALL

Presented By

Dr Rachel Rau, University of Washington, WA, USA

Trial

Phase 3, AALL1731

Conference

ASH 2024

Type

Peer-reviewed article

29 January 2025 09:57

Blinatumomab reduces toxicity in the consolidation phase in paediatric high-risk B-cell ALL

Presented By

Prof. Martin Schrappe, Hong Kong College of Paediatricians, China

Trial

Phase 3, AIEOP-BFM ALL 2017

Conference

ASH 2023

Type

Peer-reviewed article

7 February 2024 15:02

Blinatumomab candidate for standard-of-care in newly diagnosed B-ALL

Presented By

Prof. Mark Litzow, Mayo Clinic, MN, USA

Trial

Phase 3, ECOG-ACRIN-E1910 NCTN

Conference

ASH 2022

Type

Peer-reviewed article

20 February 2023 11:07

CD22-directed CAR T-cell therapy safe and well-tolerated in R/R LBCL

Expert

Dr Matthew J. Frank, Stanford University School of Medicine, USA

Conference

ASH 2021

Type

News article

4 February 2022 11:30

MRD assessment post-CAR-T predicts ALL allo-HSCT bridging

Expert

Dr Hui Wang, Hebei Yanda Ludaopei Hospital, China

Conference

EHA 2020

Type

Peer-reviewed article

9 September 2020 11:02

Likely new standard of care: Blinatumomab for children with relapsed B-ALL

Presented By

Prof. Patrick A. Brown, Johns Hopkins Kimmel Cancer Center, Baltimore, USA

Trial

Phase 3, AALL1331

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 23:15